Emma Reeve, Director at PTC THERAPEUTICS, INC. (PTCT), sold 19,206 shares at $59.53 ($1.1M) on 2023-05-22, disclosed to the SEC on 2023-05-24.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.52 | 173 | $10K | 0.9% |
| 2 | $59.53 | 2,995 | $178K | 15.6% |
| 3 | $59.53 | 2,995 | $178K | 15.6% |
| 4 | $59.53 | 3,948 | $235K | 20.6% |
| 5 | $59.53 | 3,948 | $235K | 20.6% |
| 6 | $59.52 | 157 |
| $9K |
| 0.8% |
| 7 | $59.53 | 1,093 | $65K | 5.7% |
| 8 | $59.53 | 1,093 | $65K | 5.7% |
| 9 | $59.54 | 1,402 | $83K | 7.3% |
| 10 | $59.54 | 1,402 | $83K | 7.3% |
| Total | $59.53 avg | 19,206 | $1.1M | 100% |
| Filing → |
| PTCT | SELL | 2025-11-25 | $795K | — | Filing → |
| PTCT | SELL | 2025-11-14 | $1.1M | — | Filing → |
| PTCT | SELL | 2025-10-31 | $1.1M | — | Filing → |